Search

everythinglearnresearchcommunity

for

Search:↓

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Mice with autoimmune hair loss showed signs of heart problems.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Wnt7a protein is crucial for development and tissue maintenance and plays varying roles in diseases and potential treatments.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Treat pattern hair loss with finasteride and topical minoxidil.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Hair restoration surgery can effectively increase pubic hair density, with patient satisfaction and natural results largely depending on the chosen hair pattern and graft design.

Children are at risk of health issues from exposure to platinum group elements from car exhausts.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.